2007 until April 2016: Institut Pasteur – Platform ICAReB. Management of human biological resources of the various ongoing studies Diagmicoll, CoSImmGen, meths, HAT, Verneuil, Monalisa. Support for the establishment of a development project, and continuous improvement of a processor and traceability biological samples, MBioLIMS. Involvement in quality assurance and participation in the preparation of internal and external audits.
2004-2007: Institut Pasteur – Platforme ICAReB-Molecular Immunology parasites Unit (Globex program). Detection of parasite molecules preferentially expressed on the surface of red blood cells ex vivo for the malaria Plasmodium falciparum by labeling with iodine of parasitized red blood cells. Traditionally, isolation and enrichment, different stages of the parasite Plasmodium falciparum in the blood cells and adaptation of these methods in clinical isolates.
2002-2004: Pasteur Institute – Hepacivirus Unit. Enrichment of human hepatocytes infected with HCV. Development of the production of virus-like particles.
1998-2001: Pasteur Institute – Bacteriology of Molecular and Medical Unit. Construction of the first shuttle vector in Leptospira. Study of the expression of LE1 phage DNA.
1991-1998: Pasteur Institute – human immunogenetics Unit. Study of defective strains for expression of MHC II. Preparing Pasteur during the practical work of somatic cell and molecular genetics.
1986-1991: Pasteur Institute – Service allergens. Production manager allergens, including extraction, purification of the raw materials used in the composition of APSI (allergens for a single individual) and physico chemical and bacteriological controls.
1978-1986: Pharmaceutical Companies Janssen-Le Brun. Senior Technician. Focus analytically dosage forms for obtaining the authorization of the placing on the market (AMM).
Click to view graph
Connections
Click to view timeline
Timeline
Projects
Former Teams
CV
Publications
Download-
2020The ICAReB Platform: A Human Biobank for the Institut Pasteur and Beyond, Open Journal of Bioresources. 2020; 7: 1.
-
2017Standardized whole blood stimulation improves immunomonitoring of induced immune responses in multi-center study, Clin. Immunol. 2017 Sep;.
-
2016Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study, Clin Oral Investig 2016 Nov;.
-
2015Opiorphin Levels in Fluids of Burning Mouth Syndrom Patients. A Case Control Study, Achems, Florida; 04/2015.
-
2013Rapid diagnosis of diarrhea caused by Shigella sonnei using dipsticks; comparison of rectal swabs, direct stool and stool culture, PLoS ONE 2013;8(11):e80267.
-
2012Resequencing microarray method for molecular diagnosis of human arboviral diseases, J. Clin. Virol. 2013 Mar;56(3):238-43.
-
2012Influence of pre-analytical variables on VEGF gene expression and circulating protein concentrations, Biopreserv Biobank 2012 Oct;10(5):454-61.
-
2011Dipstick test for rapid diagnosis of Shigella dysenteriae 1 in bacterial cultures and its potential use on stool samples, PLoS ONE 2011;6(10):e24830.
-
2008Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen, Blood 2008 Sep;112(6):2520-8.
-
2006A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells, J. Gen. Virol. 2006 Dec;87(Pt 12):3587-98.
-
+View full list of publications